Growth hormone study for small babies checks diabetes risk
NCT ID NCT00597480
Summary
This study aimed to understand how growth hormone treatment affects children who were born small for their gestational age. Researchers compared two different dosing methods over two years to see which better promoted growth while minimizing risks like increased insulin resistance, which can lead to type 2 diabetes. The goal was to find factors, including genetic ones, that predict how a child will respond to the treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMALL FOR GESTATIONAL AGE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hopital Saint Vincent de Paul
Paris, 75014, France
Conditions
Explore the condition pages connected to this study.